Free Acid Form Research Articles

Structural Characterization of Fibrils from Recombinant Human Islet Amyloid Polypeptide by Solid-State NMR: The Central FGAILS Segment Is Part of the β-Sheet Core.

Amyloid deposits formed from islet amyloid polypeptide (IAPP) are a hallmark of type 2 diabetes mellitus and are known to be cytotoxic to pancreatic β-cells. The molecular structure of the fibrillar form of IAPP is subject of intense research, and to date, different models exist. We present results of solid-state NMR experiments on fibrils of recombinantly expressed and uniformly 13C, 15N-labeled human IAPP in the non-amidated, free acid form. Complete sequential resonance assignments and resulting constraints on secondary structure are shown. A single set of chemical shifts is found for most residues, which is indicative of a high degree of homogeneity. The core region comprises three to four β-sheets. We find that the central 23-FGAILS-28 segment, which is of critical importance for amyloid formation, is part of the core region and forms a β-strand in our sample preparation. The eight N-terminal amino acid residues of IAPP, forming a ring-like structure due to a disulfide bridge between residues C2 and C7, appear to be well defined but with an increased degree of flexibility. This study supports the elucidation of the structural basis of IAPP amyloid formation and highlights the extent of amyloid fibril polymorphism.

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.

Hypertriglyceridemia (triglycerides > 150 mg/dL) affects ~25 % of the United States (US) population and is associated with increased cardiovascular risk. Severe hypertriglyceridemia (≥ 500 mg/dL) is also a risk factor for pancreatitis. Three omega-3 fatty acid (OM3FA) prescription formulations are approved in the US for the treatment of adults with severe hypertriglyceridemia: (1) OM3FA ethyl esters (OM3EE), a mixture of OM3FA ethyl esters, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Lovaza®, Omtryg™, and generics); (2) icosapent ethyl (IPE), EPA ethyl esters (Vascepa®); and (3) omega-3 carboxylic acids (OM3CA), a mixture of OM3FAs in free fatty acid form, primarily EPA, DHA, and docosapentaenoic acid (Epanova®). At approved doses, all formulations substantially reduce triglyceride and very-low-density lipoprotein levels. DHA-containing formulations may also increase low-density lipoprotein cholesterol. However, this is not accompanied by increased non-high-density lipoprotein cholesterol, which is thought to provide a better indication of cardiovascular risk in this patient population. Proposed mechanisms of action of OM3FAs include inhibition of diacylglycerol acyltransferase, increased plasma lipoprotein lipase activity, decreased hepatic lipogenesis, and increased hepatic β-oxidation. OM3CA bioavailability (area under the plasma concentration-time curve from zero to the last measurable concentration) is up to 4-fold greater than that of OM3FA ethyl esters, and unlike ethyl esters, the absorption of OM3CA is not dependent on pancreatic lipase hydrolysis. All three formulations are well tolerated (the most common adverse events are gastrointestinal) and demonstrate a lack of drug-drug interactions with other lipid-lowering drugs, such as statins and fibrates. OM3FAs appear to be an effective treatment option for patients with severe hypertriglyceridemia.

Interaction of Beta-Hydroxy-Beta-Methylbutyrate Free Acid and Adenosine Triphosphate on Muscle Mass, Strength, and Power in Resistance Trained Individuals

Lowery, RP, Joy, JM, Rathmacher, JA, Baier, SM, Fuller, JC Jr, Shelley, MC II, Jäger, R, Purpura, M, Wilson, SMC, and Wilson, JM. Interaction of beta-hydroxy-beta-methylbutyrate free acid and adenosine triphosphate on muscle mass, strength, and power in resistance trained individuals. J Strength Cond Res 30(7): 1843-1854, 2016-Adenosine-5'-triphosphate (ATP) supplementation helps maintain performance under high fatiguing contractions and with greater fatigue recovery demands also increase. Current evidence suggests that the free acid form of β-hydroxy-β-methylbutyrate (HMB-FA) acts by speeding regenerative capacity of skeletal muscle after high-intensity or prolonged exercise. Therefore, we investigated the effects of 12 weeks of HMB-FA (3 g) and ATP (400 mg) administration on lean body mass (LBM), strength, and power in trained individuals. A 3-phase double-blind, placebo-, and diet-controlled study was conducted. Phases consisted of an 8-week periodized resistance training program (phase 1), followed by a 2-week overreaching cycle (phase 2), and a 2-week taper (phase 3). Lean body mass was increased by a combination of HMB-FA/ATP by 12.7% (p < 0.001). In a similar fashion, strength gains after training were increased in HMB-FA/ATP-supplemented subjects by 23.5% (p < 0.001). Vertical jump and Wingate power were increased in the HMB-FA/ATP-supplemented group compared with the placebo-supplemented group, and the 12-week increases were 21.5 and 23.7%, respectively. During the overreaching cycle, strength and power declined in the placebo group (4.3-5.7%), whereas supplementation with HMB-FA/ATP resulted in continued strength gains (1.3%). In conclusion, HMB-FA and ATP in combination with resistance exercise training enhanced LBM, power, and strength. In addition, HMB-FA plus ATP blunted the typical response to overreaching, resulting in a further increase in strength during that period. It seems that the combination of HMB-FA/ATP could benefit those who continuously train at high levels such as elite athletes or military personnel.

Effect of addition of green coffee extract and nanoencapsulated chlorogenic acids on aroma of different food products

Between food polyphenols and proteinaceous compounds occur noncovalent interactions. The interactions can affect some properties of these compounds, such as nutritional value, bioactivity and organoleptic characteristics. When polyphenols are used as food additive, the changes can by limited by their encapsulation. The aim of the study was to determine, how the addition of polyphenols, i.e. chlorogenic acids, from green coffee in free form or nanoencapsulated by β-cyclodextrin and further the addition of hydrolysate of ovalbumin, whey proteins or soy proteins will affect the content and the profile of volatile aroma compounds of six food products: bread, cookies, caramel cottage cheese, nutty filling, and mushroom or meat stuffing. Considering the six food products a general trend of the content of volatile compounds caused by supplementing with the used additives was observed. The increase of aroma volatiles content in the headspace of the products increased in the following order: nanoencapsulated chlorogenic acids < control < protein hydrolysates < free chlorogenic acids < chlorogenic acids in free form with protein hydrolysates.

A solvent-free approach to extract the lipid fraction from sewer grease for biodiesel production

Fats, oils and greases (FOG) are the number one cause of sewer pipe blockage and have been mostly disposed of as a waste until recently. This study investigated a low cost and environmentally friendly approach to extract the lipid fraction (fatty acids and glycerides for biodiesel production) from sewer grease (SG), i.e., FOGs obtained from wastewater treatment plants (WWTPs). The lipid fraction of the sewer grease was primarily in the form of free fatty acid (FFA), at 20.7wt%. An innovative solvent-free extraction approach was developed using waste cooking oil (WCO) to overcome the challenges of emulsion, impurities and high moisture content of the sewer grease. A 95% extraction yield of sewer grease was achieved under the optimum operating condition of 3.2:1 WCO-SG ratio (wt/wt), 70°C and 240min. In addition, the reusability of the WCO was also investigated. WCO can be used two to three times for sewer grease extraction with more than 90% extraction efficiency.

Fish oils against Burkholderia and Pseudomonas aeruginosa: invitro efficacy and their therapeutic and prophylactic effects on infected Galleria mellonella larvae.

This study investigates the antimicrobial effects of fish oil-based formulas rich in omega-3 fatty acids (free fatty acids, ethyl esters or triacylglycerols), against cystic fibrosis (CF) pathogens (Burkholderia cenocepacia K56-2 and Pseudomonas aeruginosa PAO1), often resistant to multiple antibiotics. The fish oils have shown antibacterial efficacy, although activity was highest for the one containing the fatty acid EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in their free form (MIC value is 1·87% v/v for both pathogens). To test whether the fish oils could have a therapeutic and prophylactic potential invivo, we assessed its efficacy using a Galleria mellonella caterpillar model of infection. The treatment of infected larvae with a single dose (7h post infection) enhances the survival of larvae, being more pronounced with the free fatty acid form (EPAX 6000 FA). Moreover, we observed that the prophylactic food provision of the fish oil EPAX 6000 FA during 12days prior to bacterial infection extended the life of the infected larvae. The fish oils, particularly in the free fatty acid form, are active in killing Burkholderia and Ps.aeruginosa. The possibility of using fish oils for the treatment of bacterial infections in CF patients.

Abiotic Protein Fragmentation by Manganese Oxide: Implications for a Mechanism to Supply Soil Biota with Oligopeptides.

The ability of plants and microorganisms to take up organic nitrogen in the form of free amino acids and oligopeptides has received increasing attention over the last two decades, yet the mechanisms for the formation of such compounds in soil environments remain poorly understood. We used Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) spectroscopies to distinguish the reaction of a model protein with a pedogenic oxide (Birnessite, MnO2) from its response to a phyllosilicate (Kaolinite). Our data demonstrate that birnessite fragments the model protein while kaolinite does not, resulting in soluble peptides that would be available to soil biota and confirming the existence of an abiotic pathway for the formation of organic nitrogen compounds for direct uptake by plants and microorganisms. The absence of reduced Mn(II) in the solution suggests that birnessite acts as a catalyst rather than an oxidant in this reaction. NMR and EPR spectroscopies are shown to be valuable tools to observe these reactions and capture the extent of protein transformation together with the extent of mineral response.

Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes.

Adrenaline is a hormone that has profound actions on the cardiovascular system and is also a mediator of the fight-or-flight response. Adrenaline is now increasingly recognized as an important metabolic hormone that helps mobilize energy stores in the form of glucose and free fatty acids in preparation for physical activity or for recovery from hypoglycaemia. Recovery from hypoglycaemia is termed counter-regulation and involves the suppression of endogenous insulin secretion, activation of glucagon secretion from pancreatic α-cells and activation of adrenaline secretion. Secretion of adrenaline is controlled by presympathetic neurons in the rostroventrolateral medulla, which are, in turn, under the control of central and/or peripheral glucose-sensing neurons. Adrenaline is particularly important for counter-regulation in individuals with type 1 (insulin-dependent) diabetes because these patients do not produce endogenous insulin and also lose their ability to secrete glucagon soon after diagnosis. Type 1 diabetic patients are therefore critically dependent on adrenaline for restoration of normoglycaemia and attenuation or loss of this response in the hypoglycaemia unawareness condition can have serious, sometimes fatal, consequences. Understanding the neural control of hypoglycaemia-induced adrenaline secretion is likely to identify new therapeutic targets for treating this potentially life-threatening condition.

Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.

BackgroundDifferences in the increase in matrix metalloproteinase (MMP) and decrease in tissue inhibitor of metalloproteinase (TIMP) activity may contribute to the different characteristics observed clinically on decreased intraocular pressure in patients with glaucoma or ocular hypertension. The purpose of this study was to investigate differences in the expression profiles of MMPs and TIMPs induced by the prostaglandin analogs bimatoprost, latanoprost, and tafluprost in human non-pigmented ciliary epithelial cells (HNPCECs).MethodsHNPCECs were cultured for 24 h with 0, 10, 100, or 1000 μM of the free acid forms of bimatoprost, latanoprost, and tafluprost. We measured the expression levels of MMPs and TIMPs using real-time polymerase chain reaction, and compared the results. Enzyme activities of MMP-2 and −9 in conditioned media were measured by gelatin zymography.ResultsAll prostaglandin analogs we examined dose-dependently increased expression levels of MMP-1, −2, −3, −9, and −17, whereas expression levels of TIMP-1 and −2 decreased with increasing concentrations of each analog. Each prostaglandin analog induced different levels of increases in MMPs and decreases in TIMPs.ConclusionsUnique expression profiles of MMPs and TIMPs induced by bimatoprost, latanoprost, and tafluprost, as shown in HNPCECs, may contribute to clinically different effects on intraocular pressure decreases in patients with glaucoma or ocular hypertension.

The In vitro Effects of Nano-encapsulated Conjugated Linoleic Acid on Stability of Conjugated Linoleic Acid and Fermentation Profiles in the Rumen.

This study was aimed to evaluate the stability of conjugated linoleic acids (CLAs) by nano-encapsulation against in vitro ruminal biohydrogenation by microbial enzymatic conversion. CLAs (free fatty acid form of CLA [CLA-FFA], nano-encapsulated CLA-FFA, triglyceride form of CLA [CLA-TG], and nano-encapsulated CLA-TG) were used in the in vitro fermentation experiments. When Butyrivibrio fibrisolvens (B. fibrisolvens) was incubated with CLA-FFAs, the concentrations of cis-9, trans-11 CLA and vaccenic acid (VA) slightly was decreased and increased by nano-encapsulation, respectively. When B. fibrisolvens was incubated with CLA-TG, the concentrations of cis-9, trans-11 CLA and VA decreased, but these were increased when B. fibrisolvens was incubated with nano-encapsulated CLA-TG. The nano-encapsulation was more effective against the in vitro biohydrogenation activity of B.fibrisolvens incubated with CLA-FFA than with CLA-TG. In the in vitro ruminal incubation test, the total gas production and concentration of total volatile fatty acids incubated with nano-encapsulated CLA-FFA and CLA-TG were increased significantly after 24 h incubation (p<0.05). Nano-encapsulated CLA-FFA might, thus, improve the ruminal fermentation characteristics without adverse effects on the incubation process. In addition, nano-encapsulated CLA-FFA increased the population of Fibrobacter succinogenes and decreased the population of B. fibrisolvens population. These results indicate that nano-encapsulation could be applied to enhance CLA levels in ruminants by increasing the stability of CLA without causing adverse effects on ruminal fermentation.

Lecithin-Based Nano-emulsification Improves the Bioavailability of Conjugated Linoleic Acid.

In this study, we investigated the effects of lecithin-based nano-emulsification on the heat stability and bioavailability of conjugated linoleic acid (CLA) in different free fatty acid (FFA) and triglyceride (TG) forms. CLA nano-emulsion in TG form exhibited a small droplet size (70-120 nm) compared to CLA nano-emulsion in FFA form (230-260 nm). Nano-emulsification protected CLA isomers in TG form, but not in free form, against thermal decomposition during the heat treatment. The in vitro bioavailability test using monolayers of Caco-2 human intestinal cells showed that nano-emulsification increased the cellular uptake of CLA in both FFA and TG forms. More importantly, a rat feeding study showed that CLA content in small intestinal tissues or plasma was higher when CLA was emulsified, indicating an enhanced oral bioavailability of CLA by nano-emulsification. These results provide important information for development of nano-emulsion-based delivery systems that improve thermal stability and bioavailability of CLA.

High-Performance Aqueous Organic Flow Battery with Quinone-Based Redox Couples at Both Electrodes

We have demonstrated the repeated cycling of a redox flow cell based on water-soluble organic redox couples (ORBAT) at high voltage efficiency, coulombic efficiency and power density. These cells were successfully operated with 4,5-dihydroxybenzene-1,3-disulfonic acid (BQDS) at the positive electrode and anthraquinone-2,6-disulfonic acid (AQDS) at the negative electrode. Reduction of the voltage losses arising from mass transport limitations, and understanding of the chemical transformations of BQDS during charging have led to these improvements in performance. The specific advances reported here include the use of organic redox couples in the free-acid form, improvements to the flow field configuration, and novel high-surface-area graphite-felt electrode structures. We have identified various steps in the chemical and electrochemical transformations of BQDS during the first few cycles. We have also confirmed that the crossover of the reactants through the membrane was not significant. The performance improvements and new understanding presented here will hasten the development of ORBAT as an inexpensive and sustainable solution for large-scale electrical energy storage.

Conjugated Linoleic Acid Production by Bifidobacteria: Screening, Kinetic, and Composition.

Conjugated linoleic acids (CLA) are positional and geometric isomers of linoleic acid involved in a number of health aspects. In humans, CLA production is performed by gut microbiota, including some species of potential probiotic bifidobacteria. 128 strains of 31 Bifidobacterium species were screened with a spectrophotometric assay to identify novel CLA producers. Most species were nonproducers, while producers belonged to B. breve and B. pseudocatenulatum. GC-MS revealed that CLA producer strains yielded 9cis,11trans-CLA and 9trans,11trans-CLA, without any production of other isomers. Hydroxylated forms of LA were absent in producer strains, suggesting that the myosin-cross-reactive antigen (MCRA) protein that exerts hydratase activity is not involved in LA isomerization. Moreover, both CLA producer and nonproducer species bear a MCRA homologue. The strain B. breve WC 0421 was the best CLA producer, converting LA into 68.8% 9cis,11trans-CLA and 25.1% 9trans,11trans-CLA. Production occurred mostly during the lag and the exponential phase. For the first time, production and incorporation of CLA in biomass were assessed. B. breve WC 0421 stored CLA in the form of free fatty acids, without changing the composition of the esterified fatty acids, which mainly occurred in the plasmatic membrane.

The effect of counteranions on the molecular structures of phosphanegold(i) cluster cations formed by polyoxometalate (POM)-mediated clusterization.

The effect of counteranions on the molecular structures of phosphanegold(i) cluster cations formed by polyoxometalate (POM)-mediated clusterization was investigated. A novel intercluster compound, [{(AuLCl)2(μ-OH)}2]3[α-PMo12O40]2·3EtOH (1-PMo12), was obtained as orange-yellow plate crystals in 12.0% yield from a 6 : 1 molar ratio reaction of the monomeric phosphanegold(i) carboxylato complex [Au(RS-pyrrld)(LCl)] (RS-Hpyrrld = RS-2-pyrrolidone-5-carboxylic acid; LCl = tris(4-chlorophenyl)phosphane) in CH2Cl2 with the free acid-form of Keggin polyoxometalate (POM), H3[α-PMo12O40]·14H2O. An EtOH/H2O (5 : 1, v/v) solvent mixture was used. The dimeric cation [{(AuLCl)2(μ-OH)}2](2+) in 1-PMo12 was in a parallel-edge arrangement that was formed by self-assembly through the inter-cationic aurophilic interactions of the μ-OH-bridged dinuclear phosphanegold(i) cation. The POM anion in 1-PMo12 was successfully exchanged with a smaller PF6(-) anion by the use of an anion-exchange resin. POM-free, colorless block crystals of [{(AuLCl)3(μ3-O)}2](PF6)2·4CH2Cl2 (2-PF6) were obtained by vapor diffusion in 14.1% yield. During the synthesis of 2-PF6, a compound with mixed counteranions (one POM and one PF6(-) anion), i.e. [{(AuLCl)4(μ4-O)}]2[α-PMo12O40]PF6 (3-PMo12PF6), was obtained in 66.4% yield. Both products were characterized by elemental analysis, TG/DTA, FT-IR, (31)P{(1)H} NMR, (1)H NMR, and X-ray crystallography. X-ray crystallography revealed that the countercation in 2-PF6 was the dimeric cation of the μ3-O-bridged tris{phosphanegold(i)} species, whereas that in 3-PMo12PF6 consisted of an unusual μ4-O-bridged tetragonal-pyramidal tetrakis{phosphanegold(i)} cation. Therefore, we concluded that the POM anion significantly contributed to the stabilization of these countercations (parallel-edged arrangement in 1-PMo12 and μ4-O-bridged tetragonal-pyramid in 3-PMo12PF6). Moreover, the previously reported yellow crystals of [{(AuLF)2(μ-OH)}2]3[PMo12O40]2·3EtOH (4-PMo12: LF = tris(4-fluoro phenyl)phosphane) were successfully converted to the POM-free crystalline OTf(-) salt [{(AuLF)2(μ-OH)}2](OTf)2·0.5Et2O (4-OTf) by the use of an anion-exchange resin. X-ray crystallography also revealed that the parallel-edge arrangement of the dimeric cation in 4-PMo12 was converted to the crossed-edge arrangement of that in 4-OTf. These results illustrate that the AuOPOM and hydrogen-bonding (C-HOPOM and O-HOPOM) interactions between the phosphanegold(i) cluster cation and the Keggin POM anion in the solid state significantly contribute to the structure, composition, and stability of the phosphane gold(i) cluster cations in 4-PMo12.

Nutritional Support for Athletic Performance.

In recent years, all personnel involved in maximizing athletic performance have adopted a science-based approach to the nutritional support of athletes and active individuals. The field of sports nutrition has exploded in terms of applied research interest and publications, and also in the practical application of the research findings to the ‘real’ or ‘athletic’ world. Many of us tend to concentrate on nutrition for hydrating and fuelling the athlete during training sessions and competitions, but we realize that the ‘before, during and after exercise’ nutritional approach is also important for recovery and preparation for the next exercise session. In addition, nutrition can also play a role in circumstances that the athlete may find themselves in, such as having to lose weight while training, recovering from an injury and trying to train part-time or full-time, and deciding whether to take nutritional supplements, such as beta-alanine or sodium bicarbonate, which would be consumed in larger quantities than found in the diet. This supplement examines many of these issues. Applied researchers and sports personnel are continually learning more about the importance of nutrition for elite athletes. This issue considers the unequivocal importance of dietary and supplemental carbohydrate as the key fuel for success of elite-level endurance athletes, who work at extremely high exercise intensities. Elite team sports athletes also rely heavily on carbohydrate as a fuel, both for high-intensity aerobic-based activity and for sprint movements. Carbohydrate is the only fuel that can provide a substrate for both of these types of activities. Another advantage of carbohydrate is that it can be ingested during exercise and taken up and used by the skeletal muscles and central nervous system. During prolonged exercise at lower intensities, the provision of fat in the form of free fatty acids from adipose tissue can make a significant contribution to the contracting muscle’s fuel supply, but fat is not a high-intensity fuel. Not surprisingly, attempts to employ high-fat, low-carbohydrate diets to maximize elite athletic performance have not been successful. Fluid ingestion during exercise is also important, as body mass losses of ~2–3 % for endurance events and ~2 % for stop-and-go, decision-making sports can negatively affect elite performance. Typically, mass endurance events provide carbohydrate in liquid, gel and solid forms for participants, as well as various forms of liquids to maintain hydration. The decision on whether to engage in what we might call ‘supplemental’ sports nutrition is always something to be considered for athletes. This often involves ingesting naturally occurring substances in large quantities, such as beta-alanine to increase skeletal muscle carnosine levels and intracellular buffering capacity, or sodium bicarbonate to enhance extracellular buffering capacity. In sports that require repeated sprints and generate high levels of acidity in the muscle and blood, these nutritional supplements can improve performance in many individuals. It is also clear that nutritional support is critical in situations where athletes are attempting to lose body mass while continuing to train and prepare for competitions. Evidence suggests that lean mass can be preserved during weight loss with a sound nutritional programme. Equally important is dealing with injuries that partially or totally restrict athletes from training for varying periods of time. Nutrition can again play a major role in stimulating muscle protein synthesis and/or reducing protein breakdown during the periods of partial or total exercise restriction to counteract lean body mass losses. The Gatorade Sports Science Institute (GSSI) brought together researchers for a meeting in March 2014 to discuss these varied topics of interest to the sports nutrition world. Following the meeting, authors were asked to summarize the recent work in their topic area, resulting in the manuscripts in this Sports Medicine supplement. Lawrence L. Spriet, PhD Guest Editor

Metabolic engineering of Pichia pastoris to produce ricinoleic acid, a hydroxy fatty acid of industrial importance

Ricinoleic acid (12-hydroxyoctadec-cis-9-enoic acid) has many specialized uses in bioproduct industries, while castor bean is currently the only commercial source for the fatty acid. This report describes metabolic engineering of a microbial system (Pichia pastoris) to produce ricinoleic acid using a "push" (synthesis) and "pull" (assembly) strategy. CpFAH, a fatty acid hydroxylase from Claviceps purpurea, was used for synthesis of ricinoleic acid, and CpDGAT1, a diacylglycerol acyl transferase for the triacylglycerol synthesis from the same species, was used for assembly of the fatty acid. Coexpression of CpFAH and CpDGAT1 produced higher lipid contents and ricinoleic acid levels than expression of CpFAH alone. Coexpression in a mutant haploid strain defective in the Δ12 desaturase activity resulted in a higher level of ricinoleic acid than that in the diploid strain. Intriguingly, the ricinoleic acid produced was mainly distributed in the neutral lipid fractions, particularly the free fatty acid form, but with little in the polar lipids. This work demonstrates the effectiveness of the metabolic engineering strategy and excellent capacity of the microbial system for production of ricinoleic acid as an alternative to plant sources for industrial uses.

Phospholipid adsorption from vegetable oils on acid-activated sepiolite

In this study, adsorption of natural and model phospholipids (PL) from camelina and rapeseed oils on acid-activated sepiolite has been studied. Adsorption isotherms were determined for total phosphorus and for individual PL at different conditions. Influence of acid-degumming with citric acid as well as of type and ionic form of the phospholipid was investigated. The experimental data were correlated using the Moreau isotherm. The results show that neutral PLs, such as phosphatidylcholines, adsorb as ordered monolayers with molecular area of 1.3 nm2/molecule. Phosphatidic acids have similar adsorption capacity when in free acid form but the interaction with the clay surface is much weaker. Sodium salt gives substantially lower saturation capacity because of electrostatic repulsion between the adsorbed PL molecules and between PL and the clay surface. Calcium and magnesium salts have very low capacity and seem to be incapable to form any ordered structures on the clay surface.

Thin-skinned intrinsically defect-free asymmetric mono-esterified hollow fiber precursors for crosslinkable polyimide gas separation membranes

Engineering of spinning solution compositions, conditions and polymer molecular weight is described to create intrinsically defect-free thin-skinned precursors for high performance ester-crosslinked asymmetric hollow fiber membranes. The ultimate goal is to crosslink the precursors to provide robust performance for an aggressive natural gas feed. To provide insights free from CO2-induced changes in properties in the uncrosslinked samples, studies with less interacting O2, N2 and He feeds were also used to assess properties. The combined analyses indicate an absence of substructure resistance within the hollow fibers and an effective selective layer between 0.1 and 0.14µm. This thickness represents a valuable reduction over previously achievable values for this so-called propane-diol monoesterified crosslinkable polyimide (PDMC) polymer in defect-free asymmetric form, which were previously in the range of 0.5µm. Indeed, the significantly reduced skin layer thickness offers the potential to improve the gas separation productivity by 3.6X if this advantage can be carried forward into the ultimate crosslinked fibers. Additional comparisons to the free acid form of the precursor (without esterification) show advantages to the current less hydrophilic precursor in terms of ability to create a thinner precursor selective layer prior to crosslinking than for the free acid form. To date, the free acid analog to PDMC has only been able to be created with a 0.7µm selective layer vs. the current 0.1–0.14µm skin reported here. Optimization of the crosslinking process for both precursors is beyond the scope of this work, since it is itself, complex and still underway.

Disruption of insect isoprenoid biosynthesis with pyridinium bisphosphonates

Farnesyl diphosphate synthase (FPPS) catalyzes the condensation of the non-allylic diphosphate, isopentenyl diphosphate (IPP; C5), with the allylic diphosphate primer dimethylallyl diphosphate (DMAPP; C5) to generate the C15 prenyl chain (FPP) used for protein prenylation as well as sterol and terpene biosynthesis. Here, we designed and prepared a series of pyridinium bisphosphonate (PyrBP) compounds, with the aim of selectively inhibiting FPPS of the lepidopteran insect order. FPPSs of Drosophila melanogaster and the spruce budworm, Choristoneura fumiferana, were inhibited by several PyrBPs, and as hypothesized, larger bisphosphonates were more selective for the lepidopteran protein and completely inactive towards dipteran and vertebrate FPPSs. Cell growth of a D. melanogaster cell line was adversely affected by exposure to PyrPBs that were strongly inhibitory to insect FPPS, although their effect was less pronounced than that observed upon exposure to the electron transport disrupter, chlorfenapyr. To assess the impact of PyrBPs on lepidopteran insect growth and development, we performed feeding and topical studies, using the tobacco hornworm, Manduca sexta, as our insect model. The free acid form of a PyrBP and a known bisphosphonate inhibitor of vertebrate FPPS, alendronate, had little to no effect on larval M. sexta; however, the topical application of more lipophilic ester PyrBPs caused decreased growth, incomplete larval molting, cuticle darkening at the site of application, and for those insects that survived, the formation of larval–pupal hybrids. To gain a better understanding of the structural differences that produce selective lepidopteran FPPS inhibition, homology models of C. fumiferana and D. melanogaster FPPS (CfFPPS2, and DmFPPS) were prepared. Docking of substrates and PyrBPs demonstrates that differences at the −3 and −4 positions relative to the first aspartate rich motif (FARM) are important factors in the ability of the lepidopteran enzyme to produce homologous isoprenoid structure and to be selectively inhibited by larger PyrBPs.

Use of the guanidination reaction for determining reactive lysine, bioavailable lysine and gut endogenous lysine.

Determining the bioavailability of lysine in foods and feedstuffs is important since lysine is often the first limiting indispensable amino acid in diets for intensively farmed livestock (pigs and poultry) and also in many cereal-based diets consumed by humans. When foods or feedstuffs are heat processed, lysine can undergo Maillard reactions to produce nutritionally unavailable products. The guanidination reaction, the reaction of O-methylisourea with the side chain amino group of lysine that produces homoarginine, has been used to determine the unmodified lysine (reactive lysine) in processed foods and feedstuffs and also true ileal digestible reactive lysine (bioavailable lysine). The advantages of the guanidination method in comparison with other reactive lysine methods such as the fluorodinitrobenzene, trinitrobenzenesulphonic acid and dye-binding methods are that it is very specific for reactive lysine and also that the method is relatively straightforward to conduct. The specificity of the guanidination reaction for the lysine side chain amino group is particularly important, since ileal digesta will contain N-terminal groups in the form of free amino acids and peptides. The main disadvantage is that complete conversion of lysine to homoarginine is required, yet it is not straightforward to test for complete guanidination in processed foods and feedstuffs. Another disadvantage is that the guanidination reaction conditions may vary for different food types and sometimes within the same food type. Consequently, food-specific guanidination reaction conditions may be required and more work is needed to optimise the reaction conditions across different foods and feedstuffs.